HYDROmorphone HCl 10 mg in 0 recalled over manufacturing violations
- Recall date
- May 9, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge, 50 mL syringe (0.2 mg/mL), Rx Only, SSM Health Care Corporation Outso…
- Recall number
- D-0776-2023
- FDA classification
- Class II
- Brand / firm
- SSM Health Care St. Louis DBA SSM St. Clare Health Center
- Sold / distributed
- Product was distributed in Missouri.
Why it was recalled
CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge, 50 mL syringe (0.2 mg/mL), Rx Only, SSM Health Care Corporation Outsourcing Facility, 1015 Bowles Ave, Fenton, MO 63026-2394. NDC: 60652-0600-2
Get recall alerts
Free email alert whenever SSM Health Care St. Louis DBA SSM St. Clare Health Center has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SSM Health Care St. Louis DBA SSM St. Clare Health Center